Blog - Page 1021 of 5711

MondayApr 11, 2022 9:15 am

FuelPositive Corp. (TSX.V: NHHH) (OTCQB: NHHHF) Banking on a Decentralized Agriculture Positioning Model for a Better, Healthier Planet

Agriculture generates approximately 19-29% of total global greenhouse gas emissions and also has the highest demand for ammonia, at 80% globally This demand for ammonia is contributing to an increase in greenhouse gas emissions, through its production and additional processes FuelPositive seeks to remedy this situation with its on-site green ammonia production technology Through its decentralized agricultural positioning model, the company aims to reduce ammonia’s overall carbon footprint while also empowering farmers by giving them fertilizer and energy independence and control over supply and costs Experts have noted, with great concern, that the current food production and distribution systems are…

MondayApr 11, 2022 9:00 am

Silo Pharma Inc. (SILO) Emerging Leader as Psychedelics ‘on the Cusp of Entering Mainstream Psychiatry’

Mainstream acceptance of psychedelics took a “significant leap forward” with study results published in “Nature Medicine” Many say it is only a matter of time before FDA grants approval for psychoactive compounds to be used therapeutically SILO is focused on merging traditional therapeutics with psychedelic research for people suffering from underserved indications “The Psychedelic Revolution Is Coming,” proclaims a “New York Times” article, which notes that as a result, psychiatry may never be the same. This isn’t news for companies such as Silo Pharma (OTCQB: SILO). A developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, Silo…

MondayApr 11, 2022 9:00 am

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Leading the Charge toward Advancing Research on Treatments for Primary and Metastatic Central Nervous System Cancers

CNS Pharmaceuticals is a clinical stage biotechnology company focused on the development of novel treatments for brain tumors The company’s lead product candidate, Berubicin, is a novel anthracycline that is designed to cross the blood-brain barrier The blood-brain barrier ordinarily hinders the vascular delivery of therapeutic substances to brain tumors By crossing this protective barrier, Berubicin holds promise for the thousands of adult Americans diagnosed with malignant central nervous system cancers annually This year, about 25,050 adults (14,170 men and 10,880 women) will be diagnosed with malignant central nervous system (“CNS”) tumors – cancerous tumors that start in the spinal…

FridayApr 08, 2022 3:37 pm

QualityStocksNewsBreaks – Hero Technologies Inc. (HENC) Focusing on Expansion of Current Operations, Future Industry Growth

Hero Technologies (OTC: HENC) has made key acquisitions and investments that have played an essential role in its strategic business plan and operations. During a recent episode of the Bell2Bell Podcast hosted by Stuart Smith, company CEO Gina Serkasevich discussed HENC’s careful expansion moves. “In 2020, ‘both Highly Relaxing and the assets of V Brokers, under Veteran Hemp Co., were acquired,’ said Serkasevich. ‘Both of these entities gave Hero a foot in the door to establish itself as a cannabis player. Since then, our biggest advancement was becoming a majority stakeholder in BlackBox Systems and Technologies,’” a recent article reads.…

FridayApr 08, 2022 2:56 pm

QualityStocksNewsBreaks – Eat Well Investment Group Inc. (CSE: EWG) (OTC: EWGFF) Eyeing Additional Investments to Expand Portfolio Companies’ Reach

Eat Well Investment Group (CSE: EWG) (OTC: EWGFF), a growing company strengthening its end-to-end supply chain production of nutritious foods through strategic acquisitions, is working to overcome global forces such as the war in Ukraine in its efforts to transform entire industries such as meat and dairy with nutrition-focused operations. “The world is witnessing one of the worst global supply chains in history. Getting products in containers on planes, trains and ships to meet the demand remains a formidable task; however, I have the utmost confidence in our teams and partners…. We continue to deploy the utmost of business pragmatism…

FridayApr 08, 2022 2:29 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Hopes to Demonstrate DehydraTECH’s Superior Performance in Ongoing Epilepsy Research Program

Lexaria Bioscience Corp. (NASDAQ: LEXX) recently announced the beginning of the first phase of its epilepsy research program, EPIL-A21-1. “The research program will assess the seizure-inhibiting activity of cannabidiol (‘CBD’) administered via the company’s proprietary DehydraTECH(TM) technology, compared to the only FDA-approved CBD-based seizure medication…. The EPIL-A21-1 research program contains two main studies to be performed in rodents following the first phase – a pilot animal model that has already begun. The main studies are slated to commence in May/June and involve an acute seizure model induced by electrical stimulation and chemically induced seizure models,” a recent article reads. “Using…

FridayApr 08, 2022 1:57 pm

QualityStocksNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Gaining Momentum, Fortifying Vertically Integrated Businesses

Red White & Bloom (CSE: RWB) (OTCQX: RWBYF) has so far set base in Michigan, Florida, California, and Illinois, in what marks an aggressive and successful expansion plan. “For the balance of 2021 and throughout 2022, the company will focus on the continued growth of our top-line revenue and bottom-line results through expansion of our house of brands that continue to gain momentum, fortification of our vertically integrated businesses, and the synergies from our M&A success,” a recent article quotes Brad Rogers, the chairman and CEO of the company, as saying. RWB recently announced the acquisition of PharmaCo. “The purchase…

FridayApr 08, 2022 1:53 pm

QualityStocksNewsBreaks – Why Correlate Infrastructure Partners Inc. (CIPI) Is ‘One to Watch’

Correlate Infrastructure Partners (OTCQB: CIPI) is leading the charge toward creating an industry-leading energy solution and financing platform for the commercial and industrial sector, with its transparent, cutting-edge model changing value delivery for both facility owners and proven solution providers seeking scale. Through its two subsidiaries, Correlate and Solar Site Design, the company offers a complete suite of proprietary clean energy assessment and fulfillment solutions while simultaneously eying the tremendous market opportunity in reducing site-specific energy consumption and deploying clean energy generation and energy efficiency solutions at scale. “The opportunity exists to remove friction between today’s legacy finance process and…

FridayApr 08, 2022 1:06 pm

QualityStocksNewsBreaks – Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) Working to Capitalize on Psychedelics Therapeutics Market’s Growth

Mydecine Innovations (NEO: MYCO) (OTC: MYCOF) is a biotechnology and digital technology company aiming to transform the treatment of mental health and addiction disorders. A recent article discusses the company’s efforts to lead the charge toward developing novel psychedelic and non-psychedelic molecules for medical use. “Its research and development efforts have focused on compounds that can enable safer and more effective treatments for patients dealing with mental health and addiction disorders with unmet needs,” the article reads. “Mydecine, through its research, has positioned itself to capitalize on the opportunities in the industry, particularly with regards to psychedelic medicine for the treatment…

Site Search

Company Search